background
respiratori
syncyti
viru
respiratori
tract
virus
lead
common
cold
infant
wherea
minor
develop
acut
sever
bronchiol
often
requir
hospit
hypothes
excess
respons
respiratori
tract
viral
infect
caus
host
factor
reflect
preexist
increas
bronchial
respons
object
sought
compar
bronchial
respons
lung
function
neonat
later
develop
acut
sever
bronchiol
method
measur
infant
lung
function
n
bronchial
respons
methacholin
n
use
raisedvolum
rapid
thoracoabdomin
compress
techniqu
respiratori
symptom
neonat
copenhagen
prospect
studi
asthma
childhood
birth
cohort
born
mother
asthma
children
prospect
monitor
respiratori
symptom
given
diagnosi
acut
sever
bronchiol
accord
fix
algorithm
result
thirtyfour
infant
acut
sever
bronchiol
year
age
hospit
background
respiratori
syncyti
viru
respiratori
tract
virus
lead
common
cold
infant
wherea
minor
develop
acut
sever
bronchiol
often
requir
hospit
hypothes
excess
respons
respiratori
tract
viral
infect
caus
host
factor
reflect
preexist
increas
bronchial
respons
object
sought
compar
bronchial
respons
lung
function
neonat
later
develop
acut
sever
bronchiol
method
measur
infant
lung
function
n
bronchial
respons
methacholin
n
use
raisedvolum
rapid
thoracoabdomin
compress
techniqu
respiratori
symptom
neonat
copenhagen
prospect
studi
asthma
childhood
birth
cohort
born
mother
asthma
children
prospect
monitor
respiratori
symptom
given
diagnosi
acut
sever
bronchiol
accord
fix
algorithm
result
thirtyfour
infant
acut
sever
bronchiol
year
age
hospit
case
associ
respiratori
syncyti
viru
children
later
acut
sever
bronchiol
irrespect
viral
speci
increas
respons
methacholin
provoc
dose
methacholin
produc
decreas
transcutan
oxygen
pressur
pd
age
month
compar
control
subject
median
pd
case
vs
control
subject
vs
mmol
p
wherea
differ
baselin
airflow
signific
forc
expiratori
volum
second
mean
z
score
case
vs
control
subject
vs
p
forc
expiratori
flow
forc
vital
capac
mean
z
score
case
vs
control
subject
vs
p
conclus
bronchial
hyperrespons
atrisk
neonat
preced
acut
sever
bronchiol
respons
infect
respiratori
tract
viru
j
allergi
clin
immunol
key
word
bronchial
respons
infant
lung
function
measur
viral
bronchiol
children
acut
sever
bronchiol
relat
airway
viru
infect
respiratori
syncyti
viru
rsv
rhinoviru
increas
risk
asthma
allergi
school
age
led
suggest
causal
role
rsv
rhinoviru
risk
asthma
hand
asthma
hered
troublesom
asthmalik
symptom
earli
infanc
signific
risk
factor
subsequ
rsvrelat
hospit
infanc
suggest
host
factor
might
determin
share
predisposit
viral
bronchiol
childhood
asthma
hypothes
preexist
abnorm
infant
spirometri
bronchial
hyperrespons
neonat
preced
later
develop
acut
sever
bronchiol
recent
demonstr
neonat
pulmonari
function
associ
asthma
age
year
copenhagen
prospect
studi
asthma
childhood
copsac
present
studi
investig
whether
neonat
pulmonari
function
also
associ
acut
sever
bronchiol
infant
ie
whether
neonat
lung
function
share
host
factor
asthma
acut
sever
bronchiol
studi
nest
copsac
prospect
clinic
studi
birth
cohort
neonat
born
mother
histori
asthma
studi
includ
measur
infant
spirometri
bronchial
respons
methacholin
month
age
cohort
particip
deep
phenotyp
close
clinic
singlecent
followup
birth
cohort
copsac
physician
allow
prospect
identif
infant
develop
acut
sever
bronchiol
four
hundr
eleven
infant
born
term
mother
histori
physiciandiagnos
asthma
enrol
month
age
copsac
prospect
birth
cohort
studi
key
exclus
criteria
symptom
lower
airway
infect
neonat
mechan
ventil
inclus
gestat
age
less
week
congenit
abnorm
system
ill
studi
conduct
accord
guid
principl
declar
helsinki
approv
local
ethic
committe
kf
danish
data
protect
agenc
parent
provid
written
inform
consent
enrol
infant
spirometri
assess
sedat
oral
dose
mg
kg
chloral
hydrat
age
month
appli
raisedvolum
rapid
thoracoabdomin
compress
techniqu
agreement
american
thorac
societi
european
respiratori
societi
standard
inflat
squeez
jacket
wrap
around
sedat
infant
chest
abdomen
repeat
ventil
predefin
mouth
pressur
ensur
expans
lung
volum
instant
inflat
jacket
caus
full
exhal
flow
measur
use
pneumotachograph
aircushion
facemask
softwar
identifi
forc
vital
capac
fvc
first
plateau
volumetim
curv
measur
fvc
appear
second
forc
expiratori
volum
second
fev
less
equal
fvc
accept
three
accept
curv
obtain
measur
curv
contain
median
valu
fev
use
analys
volum
fev
flow
forc
expiratori
flow
forc
vital
capac
fef
paramet
baselin
lung
function
measur
repeat
salin
inhal
subsequ
methacholin
administ
quadrupl
dose
step
administ
dosimet
attach
nebul
spira
tsm
respiratori
care
center
ameenlinna
finland
previous
detail
bronchial
respons
assess
mean
repeat
measur
infant
spirometri
continu
assess
transcutan
oxygen
pressur
ptco
radiomet
copenhagen
denmark
provoc
dose
methacholin
produc
decreas
transcutan
oxygen
pressur
pd
estim
doserespons
curv
fit
logist
function
previou
sensit
analys
show
ptco
determin
bronchial
respons
greater
sensit
forc
flow
indic
infant
spirometri
therefor
ptco
pd
use
assess
bronchial
respons
present
analys
birth
cohort
prospect
monitor
close
respiratori
symptom
daili
diari
card
month
age
clinic
examin
perform
copsac
physician
research
clinic
everi
month
case
acut
respiratori
symptom
acut
sever
bronchiol
defin
acut
respiratori
tract
ill
onset
age
year
base
symptom
coryza
progress
day
cough
tachypnea
chest
retract
auscult
widespread
crepit
andor
rhonchi
case
infant
brought
directli
local
pediatr
emerg
depart
admiss
hospit
record
retriev
care
review
verifi
respiratori
symptom
compat
abovement
criteria
diagnos
acut
sever
bronchiol
virus
detect
mean
pcr
analysi
nasopharyng
aspir
sampl
rsv
rhinovirus
influenza
virus
b
parainfluenza
virus
coronavirus
picornavirus
bocaviru
adenovirus
human
metapneumoviru
previous
detail
bronchiol
occur
age
year
irrespect
viral
trigger
ie
bronchiol
use
primari
end
point
exclud
children
acut
asthmalik
exacerb
secondari
end
point
rsvinduc
bronchiol
nonrsvinduc
bronchiol
acut
asthmalik
exacerb
bronchiol
age
year
bronchiol
includ
acut
asthmalik
exacerb
recurr
episod
troublesom
lung
symptom
defin
consecut
day
record
signific
cough
andor
wheez
andor
dyspnea
number
episod
troublesom
lung
symptom
develop
acut
sever
bronchiol
among
case
compar
number
episod
control
group
occur
median
age
diagnosi
acut
sever
bronchiol
case
allerg
sensit
determin
age
month
mean
measur
serum
specif
ige
level
common
inhal
food
allergen
cat
dog
hors
birch
timothi
grass
mugwort
hous
dust
mite
mold
penicillium
notatum
cladosporium
herbarum
aspergillu
fumigatu
alternaria
tenui
hen
egg
cow
milk
cod
wheat
peanut
soybean
shrimp
use
immunocap
assay
pharmacia
diagnost
ab
uppsala
sweden
sensit
defin
specif
ige
level
kul
greater
test
allergen
analyz
dichotom
measur
total
ige
level
measur
age
month
use
immunocap
pharmacia
diagnost
ab
detect
limit
kul
blood
eosinophil
count
cell
per
liter
assess
age
month
eczema
diagnos
use
hanifinrajka
criteria
previous
detail
skin
lesion
describ
schedul
acut
visit
accord
predefin
morpholog
local
studi
popul
genotyp
filaggrinnul
mutat
variant
describ
detail
method
section
articl
onlin
repositori
wwwjacionlineorg
lung
function
data
fev
fef
pd
ptco
adjust
lifespan
birth
length
use
gener
linear
model
previous
detail
lifespan
examin
date
calcul
sum
estim
gestat
age
week
birth
week
sinc
birth
lung
function
measur
log
transform
analysi
obtain
normal
distribut
data
gener
linear
model
use
compar
lung
function
data
subject
without
acut
sever
bronchiol
assum
gaussian
distribut
data
use
ident
link
function
multipl
regress
analys
adjust
signific
borderlinesignific
baselin
characterist
intermediari
atop
marker
done
ad
variabl
covari
model
comparison
baselin
characterist
develop
atop
stigmata
case
versu
control
subject
done
use
univari
analys
ie
test
x
test
number
episod
troublesom
lung
symptom
case
versu
control
subject
analyz
use
poisson
regress
analys
done
sa
version
softwar
window
sa
institut
inc
cari
nc
p
valu
less
consid
signific
episod
troublesom
lung
symptom
median
iqr
episod
characterist
infant
spirometri
complet
children
bronchial
respons
methacholin
assess
children
cohort
age
month
develop
respiratori
symptom
eleven
children
episod
acut
asthmalik
symptom
fulfil
diagnost
criteria
acut
sever
bronchiol
children
exclud
lack
object
sign
respiratori
distress
tachypnea
chest
retract
see
tabl
tabl
articl
onlin
repositori
wwwjacionlineorg
baselin
characterist
exclud
children
children
exclud
case
control
group
leav
evalu
children
see
fig
articl
onlin
repositori
wwwjacionlineorg
studi
group
flow
chart
thirtyfour
children
select
cohort
acut
sever
bronchiol
age
year
median
age
diagnosi
day
interquartil
rang
iqr
day
case
n
boy
n
fever
time
diagnosi
rectal
temperatur
n
crepit
n
rhonchi
auscult
median
time
infant
spirometri
diagnosi
acut
sever
bronchiol
day
rang
day
bronchiol
case
avail
nasopharyng
aspir
rsv
identifi
bronchiol
case
wherea
remain
case
classifi
nonrsvinduc
bronchiol
picornaviru
bocaviru
rhinoviru
bocaviru
rhinoviru
human
metapneumoviru
picornaviru
influenza
viru
parainfluenza
viru
coronaviru
bocaviru
neg
nasopharyng
suction
hospit
requir
bronchiol
case
median
durat
hospit
day
iqr
day
half
admit
children
need
treatment
nasal
continu
posit
airway
pressur
one
third
prescrib
system
corticosteroid
treatment
receiv
nebul
b
agonist
children
acut
sever
bronchiol
hospit
receiv
outpati
treatment
inhal
b
agonist
inhal
corticosteroid
system
corticosteroid
antibiot
comparison
baselin
characterist
bronchiol
case
n
control
subject
n
tabl
show
matern
smoke
third
trimest
pregnanc
significantli
common
among
infant
acut
sever
bronchiol
compar
control
subject
vs
p
tt
genotyp
also
significantli
associ
develop
acut
sever
bronchiol
first
year
life
case
vs
control
subject
vs
p
wherea
male
sex
case
vs
control
subject
vs
p
young
age
start
day
care
median
age
start
case
vs
control
subject
vs
day
p
borderlin
signific
found
associ
case
control
subject
respect
anthropometr
matern
alcohol
consumpt
third
trimest
pregnanc
presenc
cat
dog
older
sibl
home
birth
household
incom
length
sole
breastfeed
patern
histori
asthma
filaggrinnul
mutat
genet
variant
tabl
children
acut
sever
bronchiol
significantli
p
episod
troublesom
lung
symptom
bronchiol
diagnosi
median
iqr
compar
control
subject
median
age
bronchiol
diagnosi
among
case
median
iqr
blood
eosinophil
count
total
ige
level
age
month
significantli
higher
case
versu
control
subject
blood
eosinophil
count
median
children
rsvinduc
bronchiol
compar
nonrsvinduc
bronchiol
younger
diagnosi
vs
day
p
often
admit
hospit
vs
p
signific
differ
develop
atop
stigmata
first
year
life
case
rsvinduc
bronchiol
nonrsvinduc
bronchiol
p
detail
descript
bronchiol
case
control
group
outlin
tabl
distribut
pd
ptco
fev
fef
measur
age
month
respiratori
symptom
children
subsequ
acut
sever
bronchiol
versu
control
subject
shown
fig
children
acut
sever
bronchiol
react
lower
dose
methacholin
compar
control
group
median
pd
ptco
dose
case
vs
control
subject
vs
mmol
p
fig
phenomenon
remain
signific
p
adjust
signific
borderlinesignific
baselin
characterist
includ
atop
intermediari
marker
sex
matern
smoke
third
trimest
age
start
day
care
genotyp
episod
troublesom
lung
symptom
total
ige
level
blood
eosinophil
count
increas
bronchial
respons
methacholin
case
versu
control
subject
confirm
sensit
analysi
includ
exclud
case
acut
asthmalik
symptom
fulfil
diagnost
criteria
acut
bronchiol
p
distribut
fev
fef
fig
b
c
suggest
lower
airflow
infant
acut
sever
bronchiol
compar
control
subject
trend
signific
mean
z
score
fev
case
vs
control
subject
vs
p
mean
z
score
fef
case
vs
control
subject
vs
p
subgroup
analysi
pd
ptco
case
rsvinduc
bronchiol
nonrsvinduc
bronchiol
exclud
case
acut
asthmalik
exacerb
bronchiol
occur
age
year
suggest
preexist
hyperrespons
airway
independ
case
definit
although
statist
power
lost
small
adjust
sex
mother
smoke
third
trimest
pregnanc
yesno
age
start
day
care
genotyp
blood
eosinophil
count
total
ige
level
age
month
episod
troublesom
lung
symptom
diagnosi
subgroup
includ
specif
rsvinduc
bronchiol
subgroup
p
subgroup
analys
baselin
fev
fef
valu
suggest
similar
trend
impair
neonat
airflow
relat
subsequ
develop
acut
sever
bronchiol
see
tabl
ii
neonat
bronchial
hyperrespons
increas
risk
acut
sever
bronchiol
earli
life
copsac
atrisk
birth
cohort
demonstr
neonat
airway
hyperrespons
preexist
host
factor
common
later
develop
acut
sever
viral
bronchiol
childhood
asthma
first
assess
premorbid
neonat
lung
function
bronchial
respons
birth
cohort
healthi
atrisk
neonat
combin
close
prospect
clinic
followup
subsequ
develop
acut
sever
bronchiol
risk
misclassif
clinic
end
point
acut
sever
bronchiol
minim
prospect
birth
cohort
close
clinic
monitor
includ
daili
diari
card
record
respiratori
symptom
visit
clinic
clinic
assess
pediatrician
visit
clinic
time
acut
respiratori
symptom
clinic
research
unit
act
primari
health
care
resourc
cohort
relat
respiratori
symptom
ensur
diagnosi
treatment
follow
predefin
algorithm
includ
standard
clinic
definit
acut
sever
bronchiol
particular
clinic
definit
acut
sever
bronchiol
base
object
assess
tachypnea
chest
retract
auscult
widespread
fine
crepit
andor
expiratori
rhonchi
sole
base
parent
report
approach
enabl
us
exclud
case
acut
sever
asthmalik
exacerb
studi
group
import
impair
pulmonari
function
earli
life
describ
associ
subsequ
recurr
asthmalik
symptom
asthma
select
process
essenti
inclus
children
acut
sever
asthmalik
exacerb
acut
sever
bronchiol
group
could
driven
find
still
sensit
analys
includ
asthmalik
exacerb
provid
similar
conclus
suggest
clinic
distinct
acut
bronchiol
acut
asthma
symptom
arbitrari
underli
pathophysiolog
similar
bronchiol
difficult
differenti
asthmalik
symptom
inde
suspect
entiti
howev
literatur
suggest
subtl
clinic
differ
repres
differ
phenotyp
precis
issu
question
studi
choos
conserv
definit
acut
bronchiol
use
strict
predefin
algorithm
includ
object
sign
respiratori
distress
line
recent
publish
review
rsvinduc
bronchiol
associ
asthma
later
life
research
hypothesi
bronchial
hyperrespons
common
caus
bronchiol
asthma
symptom
independ
viral
speci
line
report
also
rhinovirusinduc
bronchiol
increas
risk
asthma
later
life
children
rsv
studi
younger
nonrsv
case
show
differ
atop
stigmata
furthermor
adjust
analys
atop
intermediari
end
point
alter
associ
rever
long
tradit
emphas
uniqu
qualiti
rsv
analyz
number
secondari
bronchiol
end
point
rsvinduc
bronchiol
nonrsvinduc
bronchiol
acut
asthmalik
exacerb
bronchiol
age
year
bronchiol
includ
acut
asthmalik
exacerb
secondari
analys
show
similar
pattern
preexist
increas
reactiv
methacholin
case
versu
control
subject
subgroup
analys
eg
rsv
group
reach
statist
signific
probabl
lack
power
divid
main
studi
group
smaller
subgroup
similar
increas
bronchial
respons
group
infant
present
symptom
acut
sever
airway
obstruct
independ
trigger
age
onset
suggest
common
defici
rather
particular
trigger
attribut
interpret
bronchial
hyperrespons
common
underli
phenotyp
trait
infant
present
acut
sever
airway
obstruct
respons
viral
infect
clinic
practic
admit
infant
need
support
feed
tube
nasal
continu
posit
airway
pressur
suction
upper
airway
nebul
inhal
isoton
salin
b
agonist
system
steroid
depend
symptom
sever
awar
poor
evid
presum
clinic
tradit
build
concern
bronchiol
phenotyp
might
inde
asthmat
reaction
treatment
might
meaning
altern
exist
signific
strength
studi
lung
function
assess
within
narrow
age
rang
around
month
birth
base
result
infant
spirometri
stateoftheart
raisedvolum
rapid
thoracoabdomin
compress
techniqu
agreement
recogn
intern
guidelin
nonrsvinduc
bronchiol
n
asthmalik
case
n
bronchiol
case
n
largest
publish
sampl
lung
function
assess
neonat
perform
standard
condit
compris
measur
asymptomat
infant
rel
rare
preval
acut
sever
bronchiol
limit
studi
interestingli
find
significantli
lower
airflow
infant
later
bronchiol
symptom
might
suggest
bronchial
respons
primari
patholog
lead
acut
obstruct
respons
viru
later
life
airflow
limit
might
primari
patholog
altern
might
unabl
see
differ
baselin
airflow
low
number
case
hamper
statist
power
highrisk
natur
birth
cohort
might
diminish
generaliz
find
absolut
level
lung
function
bronchial
respons
might
repres
gener
popul
although
would
affect
comparison
lung
function
within
cohort
recent
studi
preterm
infant
report
palivizumab
prophylaxi
significantli
reduc
risk
recurr
wheez
children
without
atop
predisposit
wherea
effect
children
atop
famili
histori
suggest
differenti
effect
viral
infect
depend
atop
predisposit
therefor
find
extrapol
beyond
highrisk
popul
signific
associ
bronchial
hyperrespons
month
age
atrisk
children
later
develop
acut
sever
bronchiol
demonstr
preexist
propens
exagger
airway
respons
common
respiratori
tract
viral
infect
older
studi
report
trend
reduc
airflow
increas
bronchial
respons
histamin
infant
subsequ
bronchiol
n
compar
control
subject
n
studi
limit
use
infant
spirometri
volum
anchor
test
infant
wider
age
rang
week
retrospect
questionnairedefin
end
point
doctordiagnos
bronchiol
recal
parent
followup
year
age
associ
airway
hyperrespons
subsequ
develop
acut
sever
bronchiol
demonstr
studi
recent
observ
increas
risk
asthma
age
year
children
neonat
bronchial
hyperrespons
togeth
observ
evid
associ
acut
sever
bronchiol
earli
life
develop
asthma
suggest
neonat
bronchial
hyperrespons
share
host
factor
bronchiol
asthma
rather
causal
effect
bronchiol
asthma
develop
notabl
incid
acut
sever
bronchiol
studi
higher
report
studi
compar
incid
report
cohort
infant
high
preval
atop
predisposit
associ
asthma
predisposit
increas
incid
acut
bronchiol
infant
support
research
hypothesi
host
factor
respons
acut
bronchiol
children
acut
sever
bronchiol
high
preval
earli
troublesom
lung
symptom
bronchiol
increas
total
ige
level
blood
eosinophil
count
often
expos
tobacco
smoke
utero
male
sex
carri
risk
variant
start
day
care
earli
age
compar
children
acut
sever
bronchiol
previous
demonstr
risk
allel
associ
neonat
increas
bronchial
reactiv
increas
risk
asthma
earli
childhood
cohort
togeth
characterist
typic
children
risk
asthma
support
children
acut
sever
bronchiol
premorbid
constitut
includ
bronchial
hyperrespons
predispos
exagger
respons
respiratori
tract
viral
infect
later
develop
asthma
therefor
might
specul
acut
sever
bronchiol
infanc
specif
diseas
entiti
simpli
sever
earli
debut
asthma
persist
school
age
conclus
bronchial
hyperrespons
asymptomat
atrisk
neonat
preced
later
develop
acut
sever
bronchiol
suggest
preexist
common
propens
airway
develop
asthma
react
advers
common
respiratori
tract
virus
express
gratitud
children
famili
copsac
cohort
studi
support
commit
acknowledg
appreci
uniqu
effort
copsac
research
team
thank
jensen
statist
support
key
messag
rsv
respiratori
tract
virus
lead
common
cold
infant
wherea
minor
acut
sever
bronchiol
bronchial
hyperrespons
atrisk
neonat
preced
acut
sever
bronchiol
respons
respiratori
tract
viral
infect
baselin
lung
function
repeat
salin
inhal
subsequ
methacholin
administ
quadrupl
dose
step
administ
dosimet
attach
nebul
spira
tsm
respiratori
care
center
previous
detail
bronchial
respons
assess
use
repeat
measur
infant
spirometri
continu
assess
ptco
radiomet
pd
estim
doserespons
curv
fit
logist
function
previou
sensit
analys
show
ptco
sensit
forc
flow
indic
infant
spirometri
therefor
ptco
use
analys
blood
sampl
age
month
centrifug
separ
serum
serum
cell
immedi
store
analysi
thaw
dna
purifi
serum
cell
use
qiaamp
dna
blood
maxi
kit
qiagen
valencia
calif
filaggrin
genotyp
common
independ
null
mutat
perform
previous
describ
children
defin
filaggrin
mutat
carri
least
mutat
genotyp
allel
discrimin
singl
nucleotid
polymorph
chromosom
perform
previous
detail
genotyp
allel
discrimin
chromosom
perform
describ
sleiman
et
al
tabl
baselin
characterist
lung
function
result
children
acut
sever
bronchiol
first
year
life
exclud
case
acut
sever
asthmalik
exacerb
fulfil
diagnost
criteria
acut
sever
bronchiol
control
subject
